OmniAb

Emeryville, United States

OmniAb® provides access to diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.

$30.0M raised

Aug 2025

Post-IPO Equity

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OmniAb

How much funding has OmniAb raised?

OmniAb has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.

Where is OmniAb headquartered?

OmniAb is headquartered in Emeryville, United States.

What does OmniAb do?

OmniAb® provides access to diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.

What stage is OmniAb at?

OmniAb is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 25, 2025.

MLA

"OmniAb — Funding & Investors." VCBacked, August 25, 2025, https://www.vcbacked.co/company/omniab. Accessed July 2, 2026.

APA

VCBacked. (2025). OmniAb — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/omniab

Wikipedia (cite web)

{{cite web |title=OmniAb — Funding & Investors |url=https://www.vcbacked.co/company/omniab |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 25, 2025.